Employees: 334
Size Livsmed (491000.KS) is a South Korea Health Care company (Medical Specialties) with a market value of $687M, the 296th largest of 483 South Korea companies the cockpit tracks. Shares closed at ₩35,650 on 18 Nov 2026.
Performance Over six months the shares fell 46.8%, against -12.4% for the median peer and -37.2% for the South Korea market (cap-weighted) — lowest of 21 in its peer set.
Growth Revenue grew 88.8% over the last twelve months (peer median +14.8%); the operating margin is -76.6% (peer median 15.6%).
Valuation It trades at 18.1× enterprise value to sales against a peer median of 3.0× (most expensive of 21).
Capital Return on invested capital runs 28.8 points below its cost of capital (5.5% WACC).
Next results Next results expected around 29 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₩48.3B | ₩51.2B | ₩27.1B | ₩17.3B | ₩9.68B |
| Revenue growth | — | +89% | +57% | +78% | — |
| Gross profit | ₩21.9B | ₩28.8B | ₩13.9B | ₩8.97B | ₩5.08B |
| EBITDA | -₩32.5B | -₩19.9B | -₩24.9B | -₩22.9B | -₩16.4B |
| Net income | -₩38.1B | -₩22.9B | -₩25.6B | -₩57.0B | -₩59.0B |
| Free cash flow | -₩87.6B | -₩42.0B | -₩32.0B | -₩27.0B | -₩18.5B |
| Capital expenditure | ₩44.2B | ₩7.72B | ₩5.61B | ₩2.49B | ₩965M |
| Total debt | ₩42.2B | ₩11.6B | ₩8.48B | ₩33.4B | ₩30.9B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 491000.KS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -15.0% | -7.3% | 6th lowest of 21 |
| 6-month return | -46.8% | -12.4% | lowest of 21 |
| Distance from 52-week high | -62.8% | -35.1% | 3rd lowest of 21 |
| Revenue growth (TTM) | +88.8% | +14.8% | highest of 21 |
| Operating margin | -76.6% | 15.6% | lowest of 21 |
| EV / Sales | 18.1× | 3.0× | most expensive of 21 |
| ROIC minus cost of capital | -28.8 pp | +4.1 pp | lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Livsmed 491000.KS | South Korea | $687M | -47% | +89% | -77% | 18.1× | n/a | n/a |
| Delcath Systems DCTH | United States | $685M | +75% | +38% | 5% | 5.3× | 33.4% | +120.2% |
| Shenzhen Lifotronic Technology 688389.SS | China | $692M | -14% | +14% | 13% | 3.0× | 11.6% | +13.3% |
| Shanghai Sanyou Medical 688085.SS | China | $692M | -23% | +15% | 4% | 7.1× | 29.0% | +6.8% |
| Shenzhen Sunnypol Optoelectornics 002876.SZ | China | $680M | -9% | +29% | 5% | 1.6× | 10.1% | +14.2% |
| Anhui Hongyu Wuzhou Medical Manufacturer 301234.SZ | China | $697M | +148% | -14% | 3% | 10.3× | 31.8% | -0.6% |
| Shanghai INT Medical Instruments 1501.HK | Hong Kong | $700M | -25% | +35% | 21% | 3.6× | -3.3% | +23.5% |
| Japan Lifeline 7575.T | Japan | $703M | +34% | +6% | 19% | 1.7× | -9.5% | +2.9% |
| SWS Hemodialysis Care 688410.SS | China | $706M | -11% | +31% | 19% | 3.6× | 16.2% | +25.9% |
| Doctorglasses Chain 300622.SZ | China | $710M | -22% | +6% | 14% | 3.1× | -3.4% | +15.7% |
| Shanghai Kinetic Medical 300326.SZ | China | $662M | -10% | -28% | 17% | 3.8× | 6.6% | -1.9% |
| Synektik SNT.WA | Poland | $662M | +10% | +32% | 24% | 2.9× | 0.2% | +47.5% |
| QuidelOrtho QDEL | United States | $657M | -20% | -5% | -2% | 1.4× | n/a | n/a |
| Caina Technology 301122.SZ | China | $721M | +36% | +61% | 0% | 7.7× | n/a | n/a |
| AK Medical 1789.HK | Hong Kong | $642M | -23% | +16% | 26% | 2.1× | -11.5% | +6.7% |
| Shanghai Aladdin Biochemical Technology 688179.SS | China | $736M | -37% | +39% | 24% | 5.8× | 17.1% | +24.2% |
| BMC Medical 301367.SZ | China | $737M | -17% | +37% | 17% | 1.8× | -1.5% | +15.6% |
| Beijing Aerospace Changfeng 600855.SS | China | $738M | -44% | -10% | -19% | 4.5× | n/a | n/a |
| InMode INMD | United States | $741M | -8% | +2% | 18% | 0.6× | -10.8% | +12.4% |
| Shanghai Runda Medical Technology 603108.SS | China | $744M | -36% | -12% | -2% | 1.7× | 20.3% | -0.2% |
| Jiang Xi Sanxin Medtec 300453.SZ | China | $744M | -3% | +12% | 18% | 2.8× | -1.9% | +11.8% |